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Effects of chronic caffeine pre-exposure on conditioned and 
unconditioned psychomotor activity induced by nicotine and 
amphetamine in rats 
M.I. Palmatiera, E.Y.K. ~ u n ~ ~  and R.A. Bevinsa
Three experiments examined the effects of chronic pre- 
exposure to caffeine on the subsequent conditioned and 
unconditioned locomotor activating effects of nicotine or 
amphetamine in rats. Rats were given daily intraperitoneal 
injections of caffeine anhydrous (0, 10 or 30 mg/kg base) 
for 30 days. Conditioning (environment-drug pairings) 
began after the last day of caffeine pre-exposure. Pre- 
exposure to 30 mg/kg of caffeine enhanced the acute and 
chronic locomotor effects of amphetamine (0.5 mg/kg). 
A similar enhancement of activity was not seen with the 
high (0.421 mg/kg base) or low dose (0.175 mg/kg) of 
nicotine. In a drug-free test, the distinct environment paired 
with amphetamine and the high dose of nicotine evoked 
increases in activity relative to controls. Caffeine 
pre-exposure did not affect expression of this conditioned 
hyperactivity. These effects of caffeine pre-exposure on 
amphetamine-induced activity could not be attributed to 
Introduction 
Acute nicotine cliallcngc is cliaractcrized by d c ~ t ~ c s s c d  
tno tor activity rclativc to saline-injected con trols (0.210- 
0.421 rngjlrg, Stolcnnan c.t ul., 1973, 1995; Bevins r t  crL, 
2001). lblerancc to these locomotor dcpressant cffccts is 
observed by tllc second injection (Stolcrman ~ t c r l . ,  1973; 
Clark and IZi~miu; 1983). This locolnotor supprcssion 
tends to be replaced with Iiypcractivity after repcatcd 
daily exposure to nicotinc (0.210-0.421 mg/lcg; Clark and 
ICumar, 1983; Kita (.r rd., 1992; ICsir, 1994; Bcvins (V f r L ,  
2001). Rats also show heiglitened activity rclneive to 
controls with repeatcd administration of amphctariiine 
(e.g. Schoffelmeer r t  crl., 2002). In contrast to nicotinc, 
amlphetamine doses typically used to study hchaviornl 
activation do not induce an initial suppression of 
locomotor activity (Browman r t  rrl., 1998; Fraioli lJt ul., 
1999; 0.125-1.0 mg/kg in our laboratory, see later). In fact, 
the stimulant effccts of amphetamine can be seen on the 
first administration (e.g. Urowlnan rt  ~ d ,  1998). 
Conditioning to environmental cues reliably associated 
with tlie drug can contribute to the loco~notor activating 
effects of nicotinc and atnplietamine (Vezina ~t (N!, 1989; 
Reid c't dl., 1996, 1998; Ffi~ioli el nl., 1999; Bevins et  [ I / . ,  
2001). From this perspective, tlic effects of tlie drug on 
the nervous system are the unco~iditioncd stimuli (USs), 
while the resulting behavioral changes (e.g. locomotor 
non-specific effects of caffeine. Behavioural Pharmacology 
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hypcmctivity) arc the unconditioned rcsponscs (UIis). 
When these ilnco~lrtitioned drug effects rcliably occur in 
the presence of environnicntal cucs (i.e. conditioned 
stimuli or C:Ss), thc drug effects and cues can bccorne 
nssociatcd vi:~ 1'avlovi:ui conditioning processes. For 
cxalnplc, in our laboratory, nicotine-conditioned liyper- 
activity is cvirlenccd as more activity relativc to controls 
in the absence of nicotine but in rllc presence of 
environment:~l cucs (contest C:S) that have been 
rcpciltcrlly p:lircd with nicotine (Bcvins et rn!, 2001; 
I-'i~lmnticr and 13cvins, 2002; see Iicid t/ rd, 1998 for an 
altcrnativc testing protocol). 
C:hronic exposure to one drug might promote increased 
behavioral sensitivity to another drug (c.g. Vexilia fl d, 
1989; Ligi~ori fl crl., 1997; Fenu r t  rd, 2000; Bcycr c~ rd, 
2001; I,amarque r t d ,  2001; Pontieri ~ t d ,  2001; Cauli and 
Morclli, 2002). In one such study, repeated daily exposure 
to the dopiunine (DA) DZ receptor subtype agonist 
brolliocriptirlc induced hyperactivity when rats were later 
challenged with the  non-specific adenosine antago~list 
caffcinc or the adenosine A2A receptor subtype antago- 
nist SCH 58261, regardless of test environment ( k n u  
~t ell,, 2000). Of particular interest in the  present report 
is the potential for 'cross-sensitization' between caffeine 
and other drugs of abusc. Caffeine is prevalent in 
a wide variety of foods, beverages, and over-the-counter 
0955-8810 @ 2003 Lippincott Williams & Wilkins DOI: 10.1 097101 .fbp.0000069578.37661.2a 
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medications. hedliolm et (11. (1999) estimate tliat cliilclren 
aged 7-10 years ingest approximately 0.5-1.8mgllrg 
caffeine/day, primarily from soft drinks and chocolate 
products. 7% our knowledge, longitudinal assessment of 
caffeine as a rislc factor for susceptibility to later drug use 
lias riot been investigated in humans. liowever, some 
studies have identified a relationship between caffeine 
consumption and use of alcol~ol or other abused drugs 
(e.g. Istvan and Matarazzo, 1984; Brown and Renowitz, 
1989; I<osslowslti et nl., 1993). Further, caffeine intalre is a 
potential risk factor for relapse to tobacco use (e.g. 
Cummings ut r7L, 1985; I<rall rt rd ,  2002). 
Recent studics using anirnal models have confirmed 
these purported observations of cross-sensitization. Caf- 
feine prc-exposurc can enhance tlie reinforcing (Shoaib PL 
ol., 1999) and discriminative (Gasior et n/., 2000, 2002) 
effects of nicotine, as well as the acute psychomotor 
effects of nicotine, cocaine and amphetamine (Gasior ut 
nl., 2000). T h e  purpose of the  present research was to 
test the effects of chronic caffeine pre-exposure on the 
subsequent acute and chronic unconditioned locomotor 
activity induced by nicotine and a~nphetamine in rats. 
Although caffeine pre-exposure might enhance thc acute 
ambulatory effects of aniphetaniine and nicotine (e.g. 
Gasior rt nlI, 2000), its chronic effects arc unclear, Also, 
climnic drug exposure might be deleterious to associa- 
tions formed between drugs and other cues (e.g. Cappcl 
and Poulos, 1979; Iwan~oto and Williamson, 1984; Kunin et 
nl., 1999, 2000; Palmatier and Bevins, 2001; but see 
Shoaib rt n/., 1994; Bevins artd Palmatier, 2003). Thus,  
drug (US) pre-exposure in a Pavlovian drug-conditioning 
situation migllt facilitate or retard acquisition of condi- 
tioned associations, Accordingly, we also assessed how 
chronic prc-exposure to caffeine affects the acquired 
conditioned association between the context CS and the 
psychomotor effects of nicotine or amphetamine (i.e. 
context-dependent hyperactivity). 
Method 
Subjects 
One hundrcd and fifteen naive male Spraguc-Dawley rats 
from Har la~ l  Industries (Indianapolis, Indiana, USA) were 
housed individually in hanging wire-mesh cages. The rats 
weighed 150-224g on arrival. Food and water were 
continuously available in the home cage. Tlie colony 
was maincained on a 12:12 light/darlr cycle; all procedures 
were conducted in the light portion of the  cycle. Each rat 
was handled for approximately 2 min daily for 3 days prior 
co the start of the  experiment. 
Apparatus 
All pre-exposure injectiol~s toolc place in the  home cage. 
Conditioning was conducted in eight cylindrical I'VC 
activity chambers measuring 30.5cm in diameter. Each 
chamber was fitted with two infrared emicteddetector 
units located 4 cm above the wire-mesh floor tlii~t divided 
the chamber into four equal sections. Infrared beani- 
brcalrs were recorded auto~natically by a personal 
computer and served as the measure of activity. 
Experiment 1A 
This experiment sougl~t to examine tlic effects of 
clironic caffeine pre-exposure on the unconditioned 
and conditioned psychomotor effects of 0.421 mglkg 
nicotine. In our laboratory, this dose of nicotine produces 
robust conditioned hyperactivity on a drug-free test for 
conditioning (Bevins e/ d, 2001; I'almatier and Bevins, 
2002). 
Procedure 
Ccrffeiue $/Y-PX$(ISN~O. At the start of each experiment, 
rats were randomly assigned (la = 20 per dose) to one of 
three doses of caffeine (0, 10 or 30 mg/lrg). Each rat was 
injected i.p. with its assigned dosc of caffeinc once daily 
for 30 days. Injections occurred in the aftcrnoon 
(16.30 r 111). 
Co/~tex/-//ico/im P X I I ~ S L I ~ ~  (rondjtjo?/ing), Rats from each 
caffeine dose wcre randomly assigned to one of two 
conditions (I'aircd or Unpaired; n = 10 per condition). 
Nicotine conditioning began approximately 17 11 after the 
last caffeine pre-exposure injection (day 31). Paired rats 
were injecteci with 0.421 ~ n d k g  nicotine s.c. imnicdiately 
before placenient in the activity chambers. Unpaired rats 
were injected s.c. with saline immediately before 
placement. Conclitioni~ig continued once daily for 10 
days. Locomotor activity (infrared beam-brealts) was 
recorded for the entire 30-min conditioning trial. To 
equate drug exposure, approximately 6 h  after each 
conditioning trial rats assigned to the Unpaired condi- 
tions were given s.c. injections of nicotine in tlie homc 
cage; Paired rats were injected with saline. This temporal 
separation produces no evidence of conditioned excita- 
tion or inhibition i l l  the Unpaired condition. In fact, this 
protocol results in an activity profile in the Unpaired 
condition tliat is similar to that of rats never exposed to 
nicotine (see Experiment 2 of Bevins ef nl., 2001). 
Drzrg-fiee test for conditio~zilzg. Twenty-four hours after the  
last conditioning trial, rats wcre given a drug-free test. 
Prior to placement in the activity chambers for the 30- 
min test, all rats were injected s.c. with saline. 
Experiment 1 B 
Experiment 1B assessed the effects of caffeine 
pre-exposure on the subsequent unconditioned and 
conditioned effects of a lower dose of nicotine 
(0.175 mgllrg) that has wealr locomotor suppressing and 
activating effects and does not support conditioning 
(Bevins et nl., 2001). Using a lower nicotine dose might 
reveal unconditioned and conditioned effects of caffeine 
Chronic caffeine exposure Palmatier et a/. 193 
pre-exposure l-rotcntially m;~sl~ed by a higher tlicotine 
close (i.c. ceiling effect). 
Procedure 
All experi~ncntal procedures wcre identical to Experiment 
lA, except as follows. Bused on findings from Experiment 
1A (see lutcr), only tlie 0 and 3Omg/kg caff'cine prc- 
cxposurc doses were included in Experi111cnt 113, Also, 
tlie nicotine dosc was reduced to 0.175 mg/I<g. For each 
caffeine pre-exposure dose (0 or 30 mgjkg), eight rats 
received nicotinc immediutcly bcforc placement in the 
activity charnbcrs (Paired) and scvcn rats received 
nicotine in tlie home cagc (Unpaired). 
Experiment 2 
Experimcnt 2 assessed the gcnclality of the results of 
Experiment lA by ex311lining tile cf'fccts of chronic 
caffeine exposure on tlic Inter psychosnotor effccts of 
another stitnuliunt (i.e. amplietami~~e).  Given the diver- 
sity of locomotor conditionil~g protocols with amphora- 
~ n i ~ i c  (c.g. Stew~lrt (lt (//, 1994; Ahmed ot ((/, 1996; 
Bespelov and %vart:lu, 1996; Arvanitogiannis ~t crL, 2000; 
S ~ ~ t t o n  (Y ( I / ,  2000), we conducted 21 pilot study to 
examine ampl~et~uninc (0.125, 0.25, 0.5 and 1 .0 ~ng/lrg), 
using the conditioning protocol dcscribcd for nicotine. 
Meall activity counts for the dn~g-free test for condition- 
ing (11th session) are prcsetl~ed in "1~1ble 1. B:lsed on 
these results, wc selected tlie 0.5 rng/lcg anlphctaminc 
dose for Experiment 2 because it supported robust 
conditioned hyperactivity after 10 trials (cf. thc  
0.421 tng/lig nicotine dosc, Experirncnt 1A). 
Procedure 
I - o r .  Prc-cxpos ure was similar co that 
used in Expcrirnent 113. During this phase, o11e animal 
was rernovccl due LO experimenter error. Thus ,  n~lalyses 
included 20 rats in the 0 mglkg condition and 19 rats in 
the 30 n~g/lcg conditio~i. 
Table 1 Experimental conditions and mean ( f  1 SEM) activity 
counts on the drug-free test for activity (I1 th session) of the pilot 
experiment 
Amphetamine dose Group Mean (-+ 1 SEMI activity 
counts 
C o / / t ( ~ . ~ t - m l l p h ~ ~ t c ~ ~ ~ ~ i ~ ~ ~ ~  cJx/~c~.sr~r(J (tont/itiowit/g). LJnless men- 
tioncd, the procectural details for context-amphetamine 
cxposurc were identical to those in Experiments 1A and 
113. I'aired groups (11 = 10 pcr pre-exposure condition) 
received 0.5 mdlrg amphetamine i.p, immediately before 
30-min exposure to the activity chambers; i.p. saline was 
udministcred in tlie home cage approximately 0 h later. 
LInpaircd (0 mg/l<g caffeine, n = 10; 30 mg/kg caffeine, 
= 9) groups rcccived similnr treatnnent, except that 
saline \yas administered before plizcement in the ilctivity 
clinmbcrs and amphetamine was given in tlic home cage. 
I)~.~{e~fi i"('  t p . ~  .for I.~I/(/~I~IINLI,. rl'lie 30-min drug-free tcs t 
W:IS s i~nil i~r to that of Experiments IA ;111d lB, cxcept that 
saline wus i11.jcctcd i.p, 
Drugs 
Amphcta~nine hydrochloride and caffeine anhydrous 
(Sigma, St. I,ouis, Missouri, USA) were dissolved in 
salinc (0.9% NilCI) nllrl injected i.p. at 11 volumc of 
Zml/kg for caffeine and Iml/lcg for amphetamine. 
(-)-Nicotinc hydrogcn tartrate salt (Sigma) was dis- 
solvcci in saline and brought to a pH of 7.0 r 0.2 with 
a dilute NaOI-I solution. Nicoiinc was i ~ ~ j e c t c d  sac. 
LIL a V D I L I I ~ I C  of 1 ~nI/kg. I~OSC.S of caffcille and ampl~cta- 
tliinc nre expressed as tlie salt form; nicotine doscs are 
cxprcssed as the hasc fonn. 
Data analyses 
Annlyses of vilriance (ANOVAs) were usecl for ovemll 
comparisons. For cx,lmplc, omnibus ANOVAs including 
one within-subjects factor, Trial, and two hcttvcen- 
sul?jects factors, Group (I'aired or Ilnpnircd) and Ilose 
(cog. 0, 10 or 30 &kg caffeine), wcre conducted as tests 
for caffci~lc prc-exposure cfkcts  on nicotitic- or atllphe- 
tumine-induced activity. R~r thcr ,  to :~ssess the lion- 
spccific effects of caffeine exposure on activity, data fro111 
IJnpairccl groups were analyzed sep:uatcly  sing Chffcine 
Ilosc as the between-sul~jects factor and 'Ilia1 as die 
rcpcatcci measurc. This  inancuvcr provided n more 
sensitive test for possible non-specific effects of caffeine 
exposure on activity. Drug-free tests were analyzed with 
two-way ANOVAs in which Group and Dose were the 
between-sub.ject factors. A two-tailed rejection criterion 
(I-' I 0.05) w:ls used for all other analyses. 
0.1 25 malka Paired (n=8) 447.60 (43.42) 
- - 
Unpaired (n = 8) 328.90 (21.72) 
0.25 mglkg Paired (n = 8) 527.40 (53.36) 
Results 
Unpaired (n=8) 275.90 (27.20) Experiment 1A 
0.5 ~nglkg Paired (n=8) 591.40 (44.33) Non-specific effects of caffeine pre-exposure 
Unpaired (n = 8) 31 3.30 (23.62) 
498.80 (31.40) Caffei~le call have ailorcctic effects. For example, Gans 1.0 mglkg Paired (11 = 8) 
Unpaired (n=7) 31 8.90 (39.91) (1984) found that, relative to saline controls, body weight 
Using a two-way ANOVA, the main effect of amphetamine dose and food consumption were attenuated for rats chroni- 
[F(3,65)=1.13, p=0.34] and the Group Dose interaction [~(3,55)= 1.91, cally exposed to caffeine (see also ~~1Sl la t ier  and Bevins, 
P=0.141 were not significant. However, there was a significant main effecl of 2()01). 'fi test this possibility, body weight on the last d21y 
Group [F(1,55) =62.17, P<0.001 I ,  indicating that Paired rats displayed 
conditioned hyperactivity relative to Unpaired controls regardless of condition. of caffeine pre-exposure (day 30) was compared for rats 
ing dose. pre-exposeci to each dose of caffeine (0, 10 or 30 mg/kg). 
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There were no significant differences in body weight 
between caffeine doses [P(2,57) = 1.75, NS]. 
Figure 1A shows locolnotor activity across canditionillg 
trials for Unpaired groups pre-exposed to caffeine or 
saline. There  was a significant main effect of Trial 
[F(9,243) = 53.59, P < 0.0011, denoting that activity 
decreased ovcr trials. The  main effccts of Dose 
and the Dose x Trial interaction werc not significant 
[ F s <  11, indicating that, in our situation, caffeine 
pre-exposure did not affect later motor activity in a 
drug-free state. 
Nicotine-induced activity (0.421 mg/kg) 
Omnibus ANOVA examined nicotinc-induced activity 
for the Unpaired and Paired groups across conditioning 
trials (Figs 1A, B). There wcre significant main effccts of 
Trial [F(9,486) = 10.08, P < 0.0011, and of Group 
[F( 1,54) = 25.48, P < 0.0011. T h e  Group x Xial interac- 
tion was also significant [1;'(9,486) = 143.48, P < 0.011, 
indicating that, as conditioning progressed, activity for 
Paired rats increased relativc to that for Unpaired 
controls. T h e  niai~l cffect of Dose [F(2,54) = 2.20, NS] 
ant1 the Group x Dose interilction [F(2,54) = 1.91, NS], 
the Dose x Trial and the Group x Dose x Trial interac- 
tions [Fs < 11 wete not significant, 
Drug-free test 
Data from the drug-free test for conditioning are 
presented in Fig. 1C. A two-way ANOVA revealed a 
significant effect of Group [F(5,54) = 65.79, P < 0.0001], 
indicating nicotine-conditiot~ed hyperactivity in the 
Paired rats. T h e  main effect of Dose and the Group x 
Dose interaction were not significant [Fs(Z,54) 1 2.08, 
NS] . 
Experiment 1 B 
Non-specific effects of caffeine exposure 
T h e  body weight of rats on the last day of pre-exposure 
did not differ significantly across caffeine doses (0 versus 
30 mglkg) [F(1,28) = 1.57, NS]. Figure ZA shows mean 
activity counts for the two Unpaired groups. Analyses 
revealed a significant ~nain  effect of Trial 
[F(9,117) = 7.78, P <  0.011, indicating that activity in 
the Unpaired groups decreased over tlie 10 conditio~ling 
trials. T h e  ma,;, effect of Caffeine Dose and the Dose x 
Trial interaction were not significant [Fs < 1 1 ,  confirming 
that chronic pre-exposure to caffeine does not affect 
motor activity in a non-specific manner. 
Fig. 1 
(A) Unpaired groups 
5 U 0 mglkg caffeine 
3 -A- 10  mglkg caffeine 
U 30  mglkg caffeine 
1 2 3 4 5 6 7 0 9 1 0  
Trial 
(8) Paired groups 
P 
.- 
r O  
Y + 0 mg/kg caffeine 
-4- 10 mglkg caffeine 
-0- 30  mglkg caffeine 
I I I I I I I I ~  1 
1 2 3 4 5 6 7 8 9 1 0  
Trial 
(C) Drug-free test 
.r" 
.- 
.,+ II Paired 0 
- 5 9 2 350 
r L )  
ti 
Fi 
3 
100 
0 10 30 0 10 30 
Caffeine pre-exposure dose (rnglkg) 
Locomotor activity for rats treated with 0.421 mglkg nicotine 
(Experiment 1A). (A) and (B) contrast caffeine pre-exposure conditions 
for Unpaired and Paired groups across conditioning trials, respectively. 
(C) Activity on the drug-free test for conditioning. 
Nicotine-induced activity (0.175 mg/kg) 
Omnibus ANOVA exatnilled activity for the  Unpaired and 
Paired groups across conditioning trials (Figs 2A and 2B, 
respectively). There  was a significant Group x 3 i a l  
interaction [F(9,234) = 19.84, P < 0.0011, illdicati~lg that 
over the 10 conditio~~ing trials, activity in Paired groups 
increased and activity in Unpaired groups decreased. T h e  
main effects of Group, Trial, and Dose were not 4 
significant [Fs 2.84, NS]. T h e  intcractions in which 
Dose (0 or 30mg/kg) was a factor were not significant 
either [Fs 5 1.26, NS]. 
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Fig. 2 
(A) Unpaired groups 
600- 
-+- 0 mg/kg caffeine 
A 
+d 
.- 
> 
.- 
+ 30  mglkg caffeine 
+d 
m 
- 5 350- 
03 s 
, o  
i.J 
I I l l l l I I I I  
I 2 3 4 5 6 7 8 9 1 0  
Trial 
(B) Paired groups 
6001 + 0 rnglkg caffeine 
5 I +30 mgkg caffeine 
~- 
.- 
.,., T 
' 0 ° 9  
I 2 3 4 5 6 7 8 9 1 0  
Trial 
(C) Drug-free test 
1111 Paired 
0 Unpaired 
Caffeine pre-exposure dose (mglkg) 
Locomotor activity for rats treated with 0.175 mg/kg nicotine 
(Experiment 1 B). (A) and (B) contrast 0 versus 3 0  mglkg caffeine pre- 
exposure for Unpaired and Paired groups, respectively. (C) Activity data 
from the drug-free test for conditioning. 
hyperactivity in our situatioll and that caffeine pre- 
exposure did not alter this outcome. 
Experiment 2 
Non-specific effects of caffeine exposure 
As in thc previous experiments, caffeine prc-exposure did 
not altcr bocly weight [F(1,37) = 2.06, NS]. On the first 
conditioning trial (day 31) 2111 equipment failure resulted 
in tlie loss of data for 13 rats. Therefore, these data were 
analyzed scparately from the remaining trials using a 
Student's t-test (Ag. 3A). For Unpaired rats, there was no 
difference in activity between caffeine pre-exposure 
doscs on the first conditioning trial It < 11. Repeated- 
measures ANOVA examined possible non-specific effects 
of caffeine in Unpaired rats on subsequent trials ( i s .  
2-10). For the Unpaired groups, there was a significant 
riiuin effect of rTrial [F(8,136) = 3.92, P < 0.051. T h e  
main effect of Dose and thc Dose x Trial intcractio~~ were 
not significant [Ps < 11, indicating that caffeine pre- 
exposure did not have a non-specific effect on activity. 
Amphe tamine-induced activity (0.5 mg/kg) 
Trid 1 data for caffeine prc-cxposcd (Paired tz = 7, 
Unpaircd JI = 6) ancl non-prc-exposed (Paired n = 5, 
Unpaired 11 = 8) rats were analyzcd separately with a 
two-way ANOVA. Given the decrease in statistical power 
due to loss of acute amplietaminc data, combined wit11 
thc previous findings that cnffcinc potentiates activity 
induced by aniphetamine in an acute challel~gc (Gasior 
c>t ( r l ,  2000), statistical significance for this analysis 
cvas se t  at P I 0.10 (one-tailed). Tliere was a significant 
mait1 effect of Group [F(1,22) = 12.06, P < 0.011, and 
a significant Dose x Group interaction [F(1,22) = 4.07, 
lJ= 0.0561. T h e  main effect of Dose was not significant 
[1;(1,22) = 2.62, NS]. Subsequent co~npilrisons prompted 
by the Dose x Group interaction examined amphetalnine- 
treated rats ( i s .  Paired groups) relative to comparable 
saline-treated (Unpaired) controls. T h e  comparisons 
revealed that for non-pre-cxposed rats, Paired and 
IJnpairecl groups were statistically similar [ t < 1 ]  
(Fig. 3C, Trial 1). E-Iowever, chronic caffeine pre-exposure 
potentiated acute al~iphetamine-induced activity 
[ t ( l l )  = 4.21, P < 0.011 (Fig. 3D, Trial 1). 
Drug-free test 
Figure 2C shows activity from the drug-free test for 
conditioning. T h e  two-way ANOVA revealecl that the  
main effect of Group, Dose, and the Dose x Group 
interaction were not significant [A 5 2.15, NS]. No main 
effect of Group or Dose x Group interaction indicates 
that 0.175 mg/kg nicotine did not support conditioned 
Activity data illustrated in Figs 3C and D contrast Paired 
and Unpaircd groups for non-pre-exposed and caffeine 
pre-exposed rats, rcspcctivcly. Omnibus ANOVA for 
Trisls 2-10 revealed a significant main effect of Trial 
[F(8,280) = 2.75, P < 0.011, of Group [F(1,35) = 94.01, 
I-'< 0.0011, and of Dose [F(1,35) = 4.78, P < 0.051. T h e  
Group x Trial interaction [F(8,280) = 2.90, P < 0.01 f was 
also significant, indicating that activity in Paired and 
Unpaired groups diverged across trials. T h e  Dose x Group 
interaction [F(1,35) = 4.69, P < 0.051 was also signifi- 
cant; howcvc~; tlie Dose  trial and Group x Dose x Trials 
interactions were not significant [Fs 5 1.223. T h e  main 
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Locomotor activity for rats treated with 0.5 mglkg amphetamine (Experiment 2). (A) and (B) contrast 0 versus 30 mglkg caffeine pre-exposure 
for Unpaired and Paired groups, respectively. (C) and (Dl contrast Paired versus Unpaired groups for rats pre-exposed to 0 and 30rnglkg caffeine. 
(E) Activity data from the drug-free test for conditioning. * 30 mglkg pre-exposed Paired rats were more active than comparable Unpaired controls 
on Trial 1. 
effect of Dose and the Group x Dose intcraction 
indicates that pre-exposure to caffeine potentiated 
amphetarnine-induced activity (i.c. only the pre-exposed 
Paired group). This enhancerneut in activity, relative to 
tlze comparable non-preexposed group, was consistent 
across trials. 
Drug-free test 
Rgure 3E illustrates data from the drug-free test for 
conditioning. Analyses of these data revealed a main 
effect of Group [b'(1,35) = 77.97, P < 0.0011, indicating 
conditioned hyperactivity in Paired rats. T h e  main effect 
of Dose [F(1,35) = 2.621 and the  Group x Dose interac- 
tion [ F <  11 were not significant. 
Discussion 
Althougl~ caffeine can be a potent anorexic (see Gans, 
1984), there were no significant differences in weight 
between rats pre-exposed to caffeine and those pre- 
exposed to saline in the present worlr. Caffeine pre- 
exposure did not have any non-specific effects 011 initial 
activity in a novel environment or habituation (decrease 
in activity) over trials, in Unpaired rats. Thus,  differences 
in activity after chronic caffeine exposure cannot b e  
attributed to non-specific cffects on weight, environ- 
mental familiarization, or general motor activity. 
Depending on the situation, nicotine produces locomotor 
suppression in rats; tl~is suppression is rcplaced with 
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enhanced activity aftcr repeated nicotine treatment (e.g. 
C:larlie and Kurnar, 198.3; Icita c.t trL, 1992; Ksir, 1994; 
Bevins rfrd., 2001). We replicated this pattern of activity 
in controls, and found that the general biplirtsic locomoto~ 
effects of nicotine were still present after prc-exposure to 
caffcinc. Chffeinc pre-exposure did not affect r~cutc 
activity induced by 0.421 or 0.175 mg/lrg nicotine (i.c. 
first conditioning tri:ll for IJrlired rats). This outcome 
appears to contrast with prcvious caffeine prc-exposure 
research demonstrating cnlianccd hyperactivity aftcr an 
acute nicotinc clinllcnge (Chior c.t rd., 2000). I11 tliat 
study, rats were injected s.c. with nicotine (0.3 or 
0.56 ~iiE/lcg salt; 0.105 or 0.196 mdlrg expressed as base, 
respectively), aftcr which activity was monitored for 
60 min. I-Iowevel; due to tlic procedufill restrictions of 
equating nctivity tests with nicotine discrirnini~tion tests, 
activity for the first 15 min was not included in the 
analyses of that study. In contrast, we cxa~iiinctl the 
effects of nicotine imriicdiatcly after ridministriition and 
for only 30 min. More importantly, Gasior et crl. (2000) did 
not suspend cril'feine exposure bcfore the nicotinc 
challenge test; rats hacl lice access to cafkinc in the 
lionie cage until just before the nicotinc challenge. 'I'his 
manipulation opens the possibility chat tlie acute 
psyclio~iiotor cffcct was due to tlie presence of both 
drugs at the time of testing, t7~1rtlier eviclencc for this 
possibility has recently bcen publislicd. In a sirnilrlr 
nicotine-discrimination study, Gasior rf nl. (2002) demon- 
strated tliat, regardless of tlie chronic exposure condition 
(i.e, caffei~ic-water or tap-water), pretreatment with an  
i.p. injection of caffcinc (10, 17 or 30 mdljkg) enlinnccd 
genclxlizztion to a 'threshold' dose of nicotinc (i.e. 
0.05 mdkg bizsc). 'l'his fillding clearly i~ldicatcs thilt the 
co-presence of nicotinc and caffci~ie can have important 
behavioral effects. Wie the~ .  differcnccs in testing proto- 
col, or other procedural vnria~ions, such as nicotine dose, 
route of caffeine administratiori, or the co-presence of 
caffeine and nicotinc in the rat at t he  t i ~ n c  of testing, 
account for between-study differences will require 
further experimentation. 
Caffeine enhances tlie psycliomotor stimulant cffects of 
amphetamine in an ilcute challenge (Gasior rr nL, 2000). 
We co~~finned tliis finding and extended it to include a 
chronic situation (i.e. repeated daily administration for 10 
days). This outcome extends tlie literature demonstrat- 
ing that chronic exposure to one drug of abuse can 
enhance tlie effects of another drug (e.g. Vezitin ef d, 
1989; Vezina and Stewart, 1990; Kuribara, 1999; Xu and 
Domino, 1999). 
Potentiation of aniplietamine-induced locolnotor activity 
by caffeine might reflect changes In the  underlying neural 
processes cornnlon to both drugs. There  is co~lverging 
evidence that the psycliomotor effects of caffeine are 
mediated by the same ~nesolimbic dopamine structures 
implicated in the psychornotor effects of ;unplietatnine 
(c.g. Okada of {TI!, 1996, 1997; Afi~nas'ev cJt rd, 2000; 
%aliniser c.t crL, 2000). O n e  possibility is chat pre-exposurc 
LO caffeine alters tlic niesolimbic dopaminc (DA) system, 
such tliat it is Inore sensitive to amphetil~nine, For 
example, con t~ la t c ru l  rotational beh;lvior elicited by 
caffeinc in KITS wit11 utiili~t~rttl 6-liydroxydopan~ille lesions 
of thc nigro-striatol patliwly is rzttenuilted 17y tlic IIA D;! 
receptor antngonist, cticlopridc (Garrett and I-Ioltzman, 
1995). Also, tlic locomotor hyperactivity produced by 
cafi'cinc in rats is attenuated by systemic administration 
of the IIA 11, receptor subtype antagonist SCI-I 23390 
and  lie ]>A I>., receptor subtype an~agonists cticlopridc 
and sulpiridc (Garrett arid Holtzrnan, 1994). These  
al tc~lt ions ~u igh t  depend on tlie antagonistic interaction 
bctcvccn adenosine and dopaniinc receptors (e.g. k r r k  cy 
rIl., 1992, see lircdliolm rf rd, 1999 for a review). Tha t  is, 
arlcnosine~gic antagotiism by caffeine might disrupt 
inhibitory el'fects of etidogenous adenosine on LIA 131 
and receptor affinity. I-Iowcvcr, tlic potential role for 
other neurotransmitter systems altered by chronic prc- 
exposure to caffeine should not be overlooked (e.g. Slii r.t 
t d ,  1994; Jacobson c~ (id, 1996; 1;rcdliolm c.t rd,  1999; scc  
Ilaly, 1993 for a revie\v). 
Amplietamine-conditioned hyperactivity in a drug-frce 
test wris unaffected by caffeine prc-exposure, despite rlie 
cnliancenicnt of amplicta~~iine-induccd activity Similarly, 
nicotine-conditioncd hyperactivity was unaffcctcd by 
cnffeinc prc-cxposurc. Clearly, much rnore parametric 
work is required before concluding t h a ~  caffeine pre- 
exposure c;unnot retard or cnhance an association 
between enviro~irnental cues and the psycliomotor effects 
of i~mphctamine or nico~inc.  Such variables include 
umphct:zrnit~c and nicotine doscs, conrlitioning trial 
parameters (e.g. number of trials, trial duration, i~ijcction 
to placement interval), and pre-exposure parameters 
(ilcJniinistration route, inter-dose interval, dose, duration, 
etc.). 
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